Stacey Drabic
10Patents
2h-index
35Co-inventors
46Inventor score
Filing activity: Oct 10, 2012 → Jul 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10000553B2 | CD40L-specific TN3-derived scaffolds and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10457732B2 | Bispecific binding proteins and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US11279759B2 | Bispecific binding proteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11104720B2 | Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunit | Chemistry; Metallurgy | 1 | Active |
| US10588969B2 | Antibodies specific for IL-21 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11529415B2 | Antibodies specific for IL-21 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10022443B2 | Antibodies specific for IL-21 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10975155B2 | CD40L-Fc fusion polypeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| USRE49908E1 | Bispecific binding proteins and uses thereof | General | 0 | Active |
| US11555062B2 | Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.